Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIBC study: 2-Iminobiotin in neonatal perinatal asphyxia
2015-003063-12Phase 2
- Sponsor
- Neurophyxia
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of 2-iminobiotin in asphyxia neonatorum and hypoxic-ischemic encephalopathy (HIE) (3 arms), sponsored by Neurophyxia. Primary endpoints: Pharmacokinetic profile of 2-iminobiotin (pilot part) and Efficacy of 2-iminobiotin (randomized part).
02
Drugs
2-iminobiotin
03
Conditions
asphyxia neonatorumhypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on 2015-003063-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003063-12.